5-Fluorocytidine Bulk Price 2026 Global Manufacturer Quotes
The global demand for fluorinated nucleosides continues to stabilize as pharmaceutical R&D prioritizes high-value antiviral and oncology intermediates. As a critical component in genetic research and drug development, supply chain security for these specialized compounds is paramount. China remains the dominant production hub, leveraging integrated upstream access to cytosine and fluorine sources to maintain cost efficiency. However, stringent environmental compliance and safety management regarding fluorination processes have raised barriers to entry, consolidating supply among qualified entities. Procurement teams and executives must prioritize partners who demonstrate robust quality assurance alongside competitive bulk price structures. NINGBO INNO PHARMCHEM CO.,LTD. stands ready to support this demand with verified capacity and transparent documentation.
Technical Specifications and Analytical Methods
Ensuring industrial purity is essential for downstream applications, particularly when the compound serves as a probe or intermediate in sensitive biological assays. Our quality control protocols adhere to strict pharmacopeial methods to guarantee consistency across batches. The following table outlines the key physical and chemical properties expected for commercial-grade material.
| Parameter | Specification | Analytical Method |
| CAS Number | 2341-22-2 | Verification |
| Chemical Name | 5-Fluoro-cytidine | IUPAC Standard |
| Molecular Formula | C9H12FN3O5 | Mass Spectrometry |
| Melting Point | 193°C | DSC / Capillary |
| Purity (HPLC) | >98.0% | High-Performance Liquid Chromatography |
| Appearance | White Crystalline Powder | Visual / UV |
| Documentation | COA, MSDS | Batch Specific |
Troubleshooting Common Impurities and Yield Issues
Optimizing the manufacturing process for fluorinated nucleosides requires precise control over reaction conditions to minimize byproducts. Understanding potential failure points helps procurement and R&D teams validate supplier capabilities.
Managing Fluoride Ion Residues
Residual fluoride ions are a common concern in fluorination reactions. Inadequate purification can lead to catalyst poisoning in downstream steps or cytotoxicity in biological assays. Advanced ion-exchange chromatography and repeated crystallization are employed to ensure levels remain within acceptable limits defined by the COA.
Controlling Isomeric Byproducts
During the glycosylation or fluorination stages, anomeric mixtures or regioisomers may form. These impurities can complicate purification and reduce overall yield. Strict temperature control and catalyst selection during the synthesis route are critical to maintaining stereochemical integrity.
Yield Optimization Strategies
Cumulative yield loss often occurs in multi-step sequences. By optimizing solvent recovery and minimizing unit operations, manufacturers can improve cost efficiency without compromising quality. This efficiency directly impacts the stability of long-term bulk price agreements.
Industrial Packaging Options and Global Logistics Handling
Secure transport is vital for maintaining compound stability during international transit. We offer flexible packaging solutions tailored to volume requirements, ranging from kilogram-scale drums for pilot plants to tonnage-scale IBCs for industrial production. All shipments are accompanied by comprehensive documentation, including Certificates of Origin and safety data sheets. As a reliable global manufacturer, we manage complex logistics to ensure timely delivery to hubs in North America, Europe, and Asia, mitigating supply chain risks associated with customs and hazardous material handling.
Partnering with NINGBO INNO PHARMCHEM CO.,LTD. ensures access to scalable production capacity and technical support for complex projects. We invite partners to explore our capabilities for custom synthesis to meet specific structural requirements.
For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.
